Effect of Baduanjin Exercise on Chronic Periodontal Disease in Elderly

December 22, 2022 updated by: Ali Mohamed Ali ismail, Cairo University

Baduanjin-exercise Efficacy on Chronic Periodontal Disease in Elderly

The metabolic syndrome (MetS) is a spectrum of conditions that increase the risk of cardiovascular disease and diabetes mellitus. The components of MetS include dysglycemia, visceral obesity, atherogenic dyslipidemia (elevated triglycerides and low levels of high-density lipoprotein) and hypertension. An association of periodontal disease and MetS has been suggested. This association is believed to be the result of systemic oxidative stress and an exuberant inflammatory response.

Physical activity is associated as a potential tool for reduction of periodontal disease prevalence. The frequency of physical activity is directly related to a low occurrence of periodontitis.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

For 6 months, MeTS elderly (25 elderly) with chronic periodontal disease will be involved in sixty-minute Baduanjin physical training (5 session weekly). Also, for 6 months, another MeTS elderly (25 elderly) with chronic periodontal disease will serve as a control non-trained group.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Dokki
      • Giza, Dokki, Egypt
        • Recruiting
        • Faculty of Physical Therapy Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 75 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • fifty elderly with metabolic syndrome and chronic periodontal disease will be included
  • both sexes will be included

Exclusion Criteria:

  • smokers
  • elderly engaged in physical activity programs
  • any cardiovascular/respiratory diseases that obstacle the conduction of Baduanjin
  • elderly on drug therapies for chronic periodontal disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercised group
For 6 months, MeTS elderly (25 elderly) with chronic periodontal disease will be trained using sixty-minute Baduanjin training/exercise (5 times weekly)
Behavioral: Baduanjin training/exercise
For 6 months, MeTS elderly (25 elderly) with chronic periodontal disease will be trained using sixty-minute Baduanjin training/exercise (5 times weekly)
No Intervention: control group
For 6 months, MeTS elderly (25 elderly) with chronic periodontal disease will receive no training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Periodontal disease index
Time Frame: It will be assessed after 6-month intervention
it will assess periodontal health status
It will be assessed after 6-month intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Simplified oral hygiene index
Time Frame: It will be assessed after 6-month intervention
it will assess oral hygiene/cleanliness status
It will be assessed after 6-month intervention
Interleukin 1 beta
Time Frame: It will be after 6-month intervention
it will be assessed in saliva
It will be after 6-month intervention
interleukin 6
Time Frame: It will be assessed after 6-month intervention
it will be assessed in saliva
It will be assessed after 6-month intervention
superoxide dismutase
Time Frame: It will be assessed after 6-month intervention
it will be assessed in saliva
It will be assessed after 6-month intervention
total antioxidant status
Time Frame: It will be assessed after 6-month intervention
it will be assessed in saliva
It will be assessed after 6-month intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Anticipated)

May 1, 2023

Study Completion (Anticipated)

May 1, 2023

Study Registration Dates

First Submitted

July 30, 2022

First Submitted That Met QC Criteria

July 30, 2022

First Posted (Actual)

August 2, 2022

Study Record Updates

Last Update Posted (Actual)

December 23, 2022

Last Update Submitted That Met QC Criteria

December 22, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/003757

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Periodontal Disease

Clinical Trials on Baduanjin training/exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe